← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2011Last known activity
Oct 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 6 trials)
Phase 3 (6 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT06550609Lead sponsorPhase 2Oct 31, 2024
- NCT06550609Sponsor investigatorPhase 2Oct 31, 2024
- NCT04799236Lead sponsorPhase 3Apr 1, 2021
- NCT04515186Overall official - principal investigatorPhase 3Nov 9, 2020
- NCT03829917Lead sponsorPhase 2/Phase 3Feb 28, 2019
- NCT03096457Overall official - principal investigatorPhase 2/Phase 3Apr 15, 2017
- NCT03096457Lead sponsorPhase 2/Phase 3Apr 15, 2017
- NCT01300975Lead sponsorPhase 2Jan 1, 2011
- NCT01300975Study directorPhase 2Jan 1, 2011
Details
- Last known activity
- Oct 31, 2024